These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2329571)
1. Studies on hindered phenols and analogues. 2. 1,3-Benzoxathioles having SRS-A inhibiting activity. Aizawa Y; Kanai T; Hasegawa K; Yamaguchi T; Iizuka Y; Iwaoka T; Yoshioka T J Med Chem; 1990 May; 33(5):1491-6. PubMed ID: 2329571 [TBL] [Abstract][Full Text] [Related]
2. Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. Yoshioka T; Fujita T; Kanai T; Aizawa Y; Kurumada T; Hasegawa K; Horikoshi H J Med Chem; 1989 Feb; 32(2):421-8. PubMed ID: 2913302 [TBL] [Abstract][Full Text] [Related]
3. Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes. Brown FJ; Bernstein PR; Cronk LA; Dosset DL; Hebbel KC; Maduskuie TP; Shapiro HS; Vacek EP; Yee YK; Willard AK J Med Chem; 1989 Apr; 32(4):807-26. PubMed ID: 2704027 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors. Song H; Oh SR; Lee HK; Han G; Kim JH; Chang HW; Doh KE; Rhee HK; Choo HY Bioorg Med Chem; 2010 Nov; 18(21):7580-5. PubMed ID: 20870413 [TBL] [Abstract][Full Text] [Related]
5. N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure. Musser JH; Kreft AF; Bender RH; Kubrak DM; Carlson RP; Chang J; Hand JM J Med Chem; 1989 Jun; 32(6):1176-83. PubMed ID: 2498516 [TBL] [Abstract][Full Text] [Related]
6. ["Slow reacting substance of anaphylaxis": biochemical characterization and new prospects for the treatment of asthma and other allergic diseases (author's transl)]. Boeynaems JM; Delespesse G Rev Med Brux; 1981 Nov; 2(9):803-9. PubMed ID: 6798664 [No Abstract] [Full Text] [Related]
7. 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Yoshimoto T; Yokoyama C; Ochi K; Yamamoto S; Maki Y; Ashida Y; Terao S; Shiraishi M Biochim Biophys Acta; 1982 Nov; 713(2):470-3. PubMed ID: 6817808 [TBL] [Abstract][Full Text] [Related]
8. N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure. Musser JH; Kreft AF; Bender RH; Kubrak DM; Grimes D; Carlson RP; Hand JM; Chang J J Med Chem; 1990 Jan; 33(1):240-5. PubMed ID: 2104935 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the production and action of leukotrienes by MK-571 and MK-886. Ford-Hutchinson AW Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788 [No Abstract] [Full Text] [Related]
10. Synthesis and structure-activity relationships of antiallergic N-[4-[4-(1H-indol-3-yl)piperidinoalkyl]-2-thiazolyl]alkanamides possessing both antihistaminic and anti slow-reacting substance (SRS) activities. Shigenaga S; Manabe T; Matsuda H; Fujii T; Matsuo M Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1822-7. PubMed ID: 7954933 [TBL] [Abstract][Full Text] [Related]
11. The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Rokach J; Young RN Adv Exp Med Biol; 1989; 259():75-108. PubMed ID: 2560345 [No Abstract] [Full Text] [Related]
12. Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists. Musser JH; Chakraborty UR; Sciortino S; Gordon RJ; Khandwala A; Neiss ES; Pruss TP; Van Inwegen R; Weinryb I; Coutts SM J Med Chem; 1987 Jan; 30(1):96-104. PubMed ID: 3806607 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and LTD4 antagonist activity of 2-norleukotriene analogues. Ku TW; McCarthy ME; Weichman BM; Gleason JG J Med Chem; 1985 Dec; 28(12):1847-53. PubMed ID: 4068008 [TBL] [Abstract][Full Text] [Related]
15. [Biological role of lipoxygenases]. Robak J; Duniec Z Postepy Hig Med Dosw; 1983; 37(2):177-93. PubMed ID: 6320146 [No Abstract] [Full Text] [Related]
16. [Biological properties of 1,2-benzisothiazoles compounds. Anti-inflammatory and antihistaminic activity of 3-alkylaminoalkoxybenzisothizoles]. Vitali T; Gaetani E; Mantovani P; Agosti A Farmaco Sci; 1969 Apr; 24(4):440-8. PubMed ID: 4388950 [No Abstract] [Full Text] [Related]
17. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Musser JH; Kubrak DM; Chang J; Lewis AJ J Med Chem; 1986 Aug; 29(8):1429-35. PubMed ID: 3090264 [TBL] [Abstract][Full Text] [Related]
18. Quinones. 4. Novel eicosanoid antagonists: synthesis and pharmacological evaluation. Shiraishi M; Kato K; Terao S; Ashida Y; Terashita Z; Kito G J Med Chem; 1989 Sep; 32(9):2214-21. PubMed ID: 2769691 [TBL] [Abstract][Full Text] [Related]
19. Imidodisulfamides. 1. A novel class of antagonists of slow-reacting substance of anaphylaxis. Ali FE; Dandridge PA; Gleason JG; Krell RD; Kruse CH; Lavanchy PG; Snader KM J Med Chem; 1982 Aug; 25(8):947-52. PubMed ID: 7120283 [TBL] [Abstract][Full Text] [Related]